Reaction
Forced Expiratory Flow Decreased reporting signals
As of the last recalculation, Forced Expiratory Flow Decreased appears in 96 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is OMALIZUMAB (PRR 443.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Omalizumab | 62 | 443.5 | 443.8 |
| Ciclesonide | 19 | 376.8 | 377.4 |
| Terazosin Hydrochloride | 9 | 242.0 | 242.2 |